Apollo Medical Holdings Inc (NASDAQ:AMEH) has been assigned an average broker rating score of 2.00 (Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation.
Brokerages have set a 12-month consensus price target of $25.00 for the company, according to Zacks. Zacks has also assigned Apollo Medical an industry rank of 77 out of 256 based on the ratings given to its competitors.
A number of research firms have weighed in on AMEH. TheStreet upgraded shares of Apollo Medical from a “d” rating to a “c-” rating in a research report on Friday, June 28th. Zacks Investment Research upgraded shares of Apollo Medical from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 28th. Finally, ValuEngine upgraded shares of Apollo Medical from a “hold” rating to a “buy” rating in a research report on Friday.
Institutional investors have recently added to or reduced their stakes in the company. Great West Life Assurance Co. Can purchased a new stake in shares of Apollo Medical during the fourth quarter worth $99,000. SG Americas Securities LLC purchased a new stake in shares of Apollo Medical during the first quarter worth $106,000. Strs Ohio grew its holdings in shares of Apollo Medical by 98.6% during the first quarter. Strs Ohio now owns 14,300 shares of the company’s stock worth $261,000 after buying an additional 7,100 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Apollo Medical by 154.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 32,242 shares of the company’s stock worth $640,000 after buying an additional 19,561 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of Apollo Medical by 63.4% during the fourth quarter. Bank of New York Mellon Corp now owns 59,862 shares of the company’s stock worth $1,188,000 after buying an additional 23,217 shares in the last quarter. 6.64% of the stock is owned by institutional investors and hedge funds.
NASDAQ:AMEH opened at $14.86 on Tuesday. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.00 and a quick ratio of 2.00. The business’s fifty day moving average is $15.57. The firm has a market capitalization of $548.19 million, a PE ratio of 66.39, a PEG ratio of 4.49 and a beta of -0.79. Apollo Medical has a fifty-two week low of $13.36 and a fifty-two week high of $25.54.
Apollo Medical Company Profile
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Further Reading: Does a trade war provide a risk to the global economy?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.